cyclosporine- a study conducted by the Chironsalud Madrid University Hospital, has revealed that Covid patients -19, who were treated with the drug cyclosporine, had an 81% less chance of dying than those patients who did not receive such a remedy, since this drug produces, on the one hand, an anti-replicative action of the virus and, on the other hand, modifies the immune response-
